Alfadhli AA - Search Results

1

Efficacy of argon plasma coagulation compared to topical formalin application for chronic radiation proctopathy.

Alfadhli AA, Alazmi WM, Ponich T, Howard JM, Prokopiw I, Alaqeel A, Gregor JC. Alfadhli AA, et al. Can J Gastroenterol. 2008 Feb;22(2):129-32. doi: 10.1155/2008/964912. Can J Gastroenterol. 2008. PMID: 18299729 Free PMC article.

2

Impact of BNT162b2 mRNA Vaccination on the Development of Short and Long-Term Vaccine-Related Adverse Events in Inflammatory Bowel Disease: A Multi-Center Prospective Study.

Shehab M, Alrashed F, Abdullah I, Alfadhli A, Ali H, Abu-Farha M, Channanath AM, Abubaker JA, Al-Mulla F. Shehab M, et al. Front Med (Lausanne). 2022 Jun 8;9:881027. doi: 10.3389/fmed.2022.881027. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35755075 Free PMC article.

3

Quadruple therapy versus standard triple therapy for eradication of Helicobacter pylori in Kuwait.

Alboraie M, Saad M, Al-Ali J, Malik M, Asem N, Schmidt I, Alfadhli AA. Alboraie M, et al. Among authors: alfadhli aa. Arab J Gastroenterol. 2015 Sep-Dec;16(3-4):131-5. doi: 10.1016/j.ajg.2015.09.007. Epub 2015 Nov 21. Arab J Gastroenterol. 2015. PMID: 26611765 Clinical Trial.

4

Shah ND, Ventura-Cots M, Abraldes JG, Alboraie M, Alfadhli A, Argemi J, Badia-Aranda E, Arús-Soler E, Barritt AS 4th, Bessone F, Biryukova M, Carrilho FJ, Fernández MC, Dorta Guiridi Z, El Kassas M, Eng-Kiong T, Queiroz Farias A, George J, Gui W, Thurairajah PH, Hsiang JC, Husić-Selimovic A, Isakov V, Karoney M, Kim W, Kluwe J, Kochhar R, Dhaka N, Costa PM, Nabeshima Pharm MA, Ono SK, Reis D, Rodil A, Domech CR, Sáez-Royuela F, Scheurich C, Siow W, Sivac-Burina N, Dos Santos Traquino ES, Some F, Spreckic S, Tan S, Vorobioff J, Wandera A, Wu P, Yacoub M, Yang L, Yu Y, Zahiragic N, Zhang C, Cortez-Pinto H, Bataller R. Shah ND, et al. Clin Gastroenterol Hepatol. 2019 Oct;17(11):2320-2329.e12. doi: 10.1016/j.cgh.2019.01.026. Epub 2019 Jan 29. Clin Gastroenterol Hepatol. 2019. PMID: 30708110 Free PMC article.

5

Effectiveness of inspectors' team in increasing compliance with personal protective equipment use and reducing COVID19 infection spread among healthcare workers.

Shehab M, Shuaibi S, Qadhi I, Alfadhli A. Shehab M, et al. Infect Prev Pract. 2021 Jun;3(2):100137. doi: 10.1016/j.infpip.2021.100137. Epub 2021 Mar 29. Infect Prev Pract. 2021. PMID: 34316577 Free PMC article.

6

Immunogenicity of BNT162b2 Vaccine in Patients with Inflammatory Bowel Disease on Infliximab Combination Therapy: A Multicenter Prospective Study.

Shehab M, Abu-Farha M, Alrashed F, Alfadhli A, Alotaibi K, Alsahli A, Alphonse Thanaraj T, Channanath A, Ali H, Abubaker J, Almulla F. Shehab M, et al. J Clin Med. 2021 Nov 18;10(22):5362. doi: 10.3390/jcm10225362. J Clin Med. 2021. PMID: 34830644 Free PMC article.

7

Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies.

Shehab M, Alrashed F, Alfadhli A, Alotaibi K, Alsahli A, Mohammad H, Cherian P, Al-Khairi I, Alphonse Thanaraj T, Channanath A, Ali H, Abu-Farha M, Abubaker J, Al-Mulla F. Shehab M, et al. Vaccines (Basel). 2021 Dec 13;9(12):1471. doi: 10.3390/vaccines9121471. Vaccines (Basel). 2021. PMID: 34960217 Free PMC article.

8

Immunogenicity of BNT162b2 Vaccine Booster Dose in Patients With Inflammatory Bowel Disease Receiving Infliximab Combination Therapy: A Prospective Observational Study.

Shehab M, Alrashed F, Alfadhli A, Alsayegh A, Aldallal U, Alsayegh M, Cherian P, Alkhair I, Thanaraj TA, Channanath A, Dashti AA, Albanaw A, Ali H, Abu-Farha M, Abubaker J, Al-Mulla F. Shehab M, et al. Among authors: alfadhli a. Front Med (Lausanne). 2022 Jul 4;9:933996. doi: 10.3389/fmed.2022.933996. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35860742 Free PMC article.

9

COVID-19 Vaccine Booster Dose Willingness among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study.

Shehab M, Alrashed F, Alfadhli A. Shehab M, et al. Vaccines (Basel). 2022 Jul 22;10(8):1166. doi: 10.3390/vaccines10081166. Vaccines (Basel). 2022. PMID: 35893815 Free PMC article.

10

A Randomized Clinical Trial Comparing Triple Therapy versus Non-bismuth based Quadruple Therapy for the Eradication of Helicobacter Pylori in Kuwait.

Alfadhli A, Alboraie M, Afifi M, Dangi A. Alfadhli A, et al. J Glob Infect Dis. 2022 Aug 26;14(3):99-105. doi: 10.4103/jgid.jgid_13_22. eCollection 2022 Jul-Sep. J Glob Infect Dis. 2022. PMID: 36237565 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page